Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Enrolling by invitation × toripalimab × Clear all

Phase

Status

Unknown 16 Completed 9 Recruiting 4 Terminated 3 Not yet recruiting 3 Active not recruiting 3 Withdrawn 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

toripalimab 1 ibrutinib 1 fludarabine 1 Spinal Puncture 1 Positron-Emission Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 JNJ-64619178 1 JNJ-64264681 1 Dexamethasone 1 Deoxycholic Acid 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06882876 2025-09-19

JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study

Xiangya Hospital of Central South University

Phase 1 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡